NO20085184L - Stabiliserte insulinlignende vekstfaktorpolypeptider - Google Patents
Stabiliserte insulinlignende vekstfaktorpolypeptiderInfo
- Publication number
- NO20085184L NO20085184L NO20085184A NO20085184A NO20085184L NO 20085184 L NO20085184 L NO 20085184L NO 20085184 A NO20085184 A NO 20085184A NO 20085184 A NO20085184 A NO 20085184A NO 20085184 L NO20085184 L NO 20085184L
- Authority
- NO
- Norway
- Prior art keywords
- growth factor
- factor polypeptides
- stabilized insulin
- igf
- stabilized
- Prior art date
Links
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 title abstract 2
- 102000013275 Somatomedins Human genes 0.000 title 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 abstract 1
- 102000048143 Insulin-Like Growth Factor II Human genes 0.000 abstract 1
- 108090001117 Insulin-Like Growth Factor II Proteins 0.000 abstract 1
- 238000003776 cleavage reaction Methods 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000007017 scission Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Physical Education & Sports Medicine (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Ophthalmology & Optometry (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81234906P | 2006-06-09 | 2006-06-09 | |
| US86224406P | 2006-10-20 | 2006-10-20 | |
| US89718707P | 2007-01-24 | 2007-01-24 | |
| PCT/US2007/070468 WO2007146689A2 (en) | 2006-06-09 | 2007-06-06 | Stabilized insulin-like growth factor polypeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20085184L true NO20085184L (no) | 2009-03-03 |
Family
ID=38801859
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20085184A NO20085184L (no) | 2006-06-09 | 2008-12-11 | Stabiliserte insulinlignende vekstfaktorpolypeptider |
| NO20085183A NO20085183L (no) | 2006-06-09 | 2008-12-11 | Stabiliserte insulinlignende vekstfaktorpolypeptider |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20085183A NO20085183L (no) | 2006-06-09 | 2008-12-11 | Stabiliserte insulinlignende vekstfaktorpolypeptider |
Country Status (33)
| Country | Link |
|---|---|
| US (4) | US20100173839A1 (ko) |
| EP (2) | EP2032154A2 (ko) |
| JP (2) | JP2009539805A (ko) |
| KR (1) | KR101459789B1 (ko) |
| AR (1) | AR061242A1 (ko) |
| AU (2) | AU2007255419A1 (ko) |
| BR (2) | BRPI0712147A2 (ko) |
| CA (2) | CA2654944C (ko) |
| CL (1) | CL2007001614A1 (ko) |
| CR (2) | CR10432A (ko) |
| CY (1) | CY1116117T1 (ko) |
| DK (2) | DK2032155T3 (ko) |
| EC (1) | ECSP088949A (ko) |
| ES (1) | ES2529261T3 (ko) |
| GT (1) | GT200800273A (ko) |
| HK (1) | HK1126429A1 (ko) |
| HR (1) | HRP20150326T1 (ko) |
| IL (1) | IL195156A (ko) |
| JO (1) | JO2968B1 (ko) |
| MA (1) | MA30503B1 (ko) |
| MX (2) | MX2008015657A (ko) |
| MY (1) | MY147856A (ko) |
| NO (2) | NO20085184L (ko) |
| NZ (2) | NZ572548A (ko) |
| PE (1) | PE20080715A1 (ko) |
| PL (1) | PL2032155T3 (ko) |
| PT (1) | PT2032155E (ko) |
| RU (1) | RU2477287C2 (ko) |
| SI (1) | SI2032155T1 (ko) |
| TN (1) | TNSN08509A1 (ko) |
| TW (1) | TWI427084B (ko) |
| UA (1) | UA97953C2 (ko) |
| WO (2) | WO2007141309A2 (ko) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090318355A1 (en) * | 2006-02-15 | 2009-12-24 | Chen Thomas T | Compositions and methods for promoting tissue repair and wound healing |
| EP2032154A2 (en) * | 2006-06-09 | 2009-03-11 | Novartis Ag | Stabilized insulin-like growth factor polypeptides |
| BRPI0912225A2 (pt) | 2008-05-07 | 2018-03-20 | Zystor Therapeutics, Inc. | peptídeos de direcionamento lisossomais e usos dos mesmos |
| CA2743072A1 (en) * | 2008-11-10 | 2010-05-14 | Novartis Ag | Antibodies to modified human igf-1/e peptides |
| WO2010088502A2 (en) * | 2009-01-30 | 2010-08-05 | The Regents Of The University Of California | Insulin-like growth factor signaling and integrin |
| EA027071B1 (ru) | 2009-04-27 | 2017-06-30 | Новартис Аг | АНТИТЕЛО К ActRIIB И СОДЕРЖАЩАЯ ЕГО КОМПОЗИЦИЯ |
| CN102510757B (zh) | 2009-07-22 | 2015-03-18 | 益普生制药股份有限公司 | 在第59位置处具有氨基酸替换的胰岛素样生长因子-1(igf-1)类似物 |
| EP2498796B1 (en) * | 2009-11-09 | 2017-12-27 | AAL Scientifics, Inc. | Treatment of heart disease |
| JP2011160696A (ja) * | 2010-02-08 | 2011-08-25 | Novartis Ag | 修飾ヒトｉｇｆ−１／ｅペプチドに対する抗体 |
| EA201391041A1 (ru) | 2011-02-23 | 2014-04-30 | Массачусетс Инститьют Оф Текнолоджи | Растворимые в воде мембранные белки и способы их получения и применения |
| WO2012178146A1 (en) * | 2011-06-24 | 2012-12-27 | Isis Pharmaceuticals, Inc. | Compositions and methods for treatment of spinal muscular atrophy |
| PT2726099T (pt) | 2011-07-01 | 2018-11-13 | Novartis Ag | Método para o tratamento de distúrbios metabólicos |
| WO2014012025A2 (en) * | 2012-07-13 | 2014-01-16 | The Trustees Of The University Of Pennsylvania | Igf-1 proteins and therapeutic uses thereof |
| CN105121462B (zh) | 2012-12-18 | 2019-08-02 | 诺华股份有限公司 | 稳定化的胰岛素样生长因子多肽 |
| CN104884467A (zh) * | 2012-12-18 | 2015-09-02 | 诺华股份有限公司 | 在遗传修饰的哺乳动物细胞中生产治疗性蛋白质 |
| TN2016000057A1 (en) | 2013-08-14 | 2017-07-05 | Novartis Ag | Methods of treating sporadic inclusion body myositis |
| AU2014330853A1 (en) * | 2013-10-02 | 2016-02-25 | National Institutes Of Health | Insulin-like growth factor mimetics for use in therapy |
| UY35874A (es) | 2013-12-12 | 2015-07-31 | Novartis Ag | Un proceso para la preparación de una composición de proteínas pegiladas |
| CA2933610C (en) | 2013-12-19 | 2023-01-24 | Puretein Bioscience Llc | Methods for treating a viral infection using igf in an animal |
| WO2015111008A2 (en) | 2014-01-27 | 2015-07-30 | Novartis Ag | Biomarkers predictive of muscle atrophy, method and use |
| US10373702B2 (en) | 2014-03-27 | 2019-08-06 | Massachusetts Institute Of Technology | Water-soluble trans-membrane proteins and methods for the preparation and use thereof |
| WO2015149085A2 (en) * | 2014-03-27 | 2015-10-01 | Massachusetts Institute Of Technology | Warer-soluble trans-membrane proteins and methods for the preparation and use thereof |
| TW201622746A (zh) | 2014-04-24 | 2016-07-01 | 諾華公司 | 改善或加速髖部骨折術後身體復原之方法 |
| US20180021410A1 (en) * | 2015-02-04 | 2018-01-25 | Puretein Bioscience Llc | Methods for increasing performance characteristics in offspring |
| KR101669140B1 (ko) * | 2015-04-28 | 2016-10-26 | (주)케어젠 | 항비만 및 항당뇨 효능을 갖는 펩타이드 및 이의 용도 |
| US11534466B2 (en) | 2016-03-09 | 2022-12-27 | Aal Scientifics, Inc. | Pancreatic stem cells and uses thereof |
| JP7339159B2 (ja) | 2017-03-24 | 2023-09-05 | ノバルティス アーゲー | 心疾患の予防および治療方法 |
| JP6691503B2 (ja) * | 2017-04-13 | 2020-04-28 | 任天堂株式会社 | ゲームプログラム、ゲーム処理制御方法、およびゲーム装置 |
| JOP20190245A1 (ar) | 2017-04-20 | 2019-10-15 | Novartis Ag | أنظمة توصيل إطلاق مستدام تتضمن روابط بلا أثر لنقطة الربط |
| TW202342509A (zh) * | 2022-01-31 | 2023-11-01 | 國立大學法人信州大學 | 以IGF1R為標的之pre-pro前驅體型嵌合抗原受體表現細胞 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4980286A (en) * | 1985-07-05 | 1990-12-25 | Whitehead Institute For Biomedical Research | In vivo introduction and expression of foreign genetic material in epithelial cells |
| WO1987001038A1 (en) | 1985-08-22 | 1987-02-26 | Commonwealth Scientific And Industrial Research Or | Peptide analogues of mammalian insulin-like growth factor-1 |
| EP0346429B1 (en) | 1987-12-24 | 1994-12-28 | Gropep Pty. Ltd. | Peptide analogues of insulin-like growth factor 1 (igf-1) or factor 2 (igf-2) |
| GB8819826D0 (en) * | 1988-08-20 | 1988-09-21 | Kabivitrum Ab | Glycosylated igf-1 |
| CA2135306A1 (en) * | 1992-05-08 | 1993-11-25 | Bradford A. Jameson | Igf-1 analogs |
| AU1178395A (en) | 1993-11-12 | 1995-05-29 | North Shore University Hospital Research Corporation | Method of treating muscular dystrophy |
| CA2190752A1 (en) | 1994-05-24 | 1995-11-30 | George N. Cox | Modified insulin-like growth factors |
| GB9605124D0 (en) | 1996-03-11 | 1996-05-08 | Royal Free Hosp School Med | Method of treating muscular disorders |
| US7118752B2 (en) * | 1998-07-22 | 2006-10-10 | University Of Connecticut | Compositions and methods for inhibiting the proliferation and invasiveness of malignant cells comprising E-domain peptides of IGF-I |
| DE60016560T2 (de) * | 1999-01-06 | 2005-12-15 | Genentech, Inc., South San Francisco | Mutierte variante des insulin-ähnlichen wachstumsfaktor-i (igf-i) |
| GB9926968D0 (en) | 1999-11-15 | 2000-01-12 | Univ London | Treatment of neurological disorders |
| GB0011278D0 (en) | 2000-05-10 | 2000-06-28 | Univ London | Repair of nerve damage |
| JP2005502322A (ja) * | 2001-04-19 | 2005-01-27 | ザ スクリップス リサーチ インスティテュート | 非天然アミノ酸のインビボ組込み |
| SE0104140D0 (sv) * | 2001-12-07 | 2001-12-07 | Astrazeneca Ab | Novel Compounds |
| GB0202906D0 (en) | 2002-02-07 | 2002-03-27 | Univ London | Prevention of myocardial damage |
| US20070185017A1 (en) | 2002-10-29 | 2007-08-09 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| WO2005033134A2 (en) * | 2003-09-30 | 2005-04-14 | Regeneron Pharmaceuticals, Inc. | Secreted protein therapeutics and uses thereof |
| GB0426154D0 (en) * | 2004-11-29 | 2004-12-29 | European Molecular Biology Lab Embl | IGF-1 novel peptides |
| EP1674113A1 (en) | 2004-12-22 | 2006-06-28 | F. Hoffmann-La Roche Ag | Conjugates of insulin-like growth factor-1 (IGF-1) and poly(ethylene glycol) |
| ATE517120T1 (de) * | 2005-01-07 | 2011-08-15 | Regeneron Pharma | Igf-1 fusion polypeptide und deren therapeutische verwendung |
| CA2601227A1 (en) | 2005-03-18 | 2006-09-21 | Ucl Business Plc | Mecano growth factor peptides and their use |
| JP2008533114A (ja) * | 2005-03-18 | 2008-08-21 | ユーシーエル ビジネス パブリック リミテッド カンパニー | メカノ成長因子ペプチドおよびその使用 |
| WO2006106689A1 (ja) | 2005-03-31 | 2006-10-12 | Pioneer Corporation | アップグレードモジュール、アプリケーションプログラム、サーバ、及びアップグレードモジュールの配信システム |
| EP2032154A2 (en) | 2006-06-09 | 2009-03-11 | Novartis Ag | Stabilized insulin-like growth factor polypeptides |
-
2007
- 2007-06-06 EP EP07729975A patent/EP2032154A2/en not_active Withdrawn
- 2007-06-06 CA CA2654944A patent/CA2654944C/en not_active Expired - Fee Related
- 2007-06-06 US US12/303,623 patent/US20100173839A1/en not_active Abandoned
- 2007-06-06 TW TW096120340A patent/TWI427084B/zh not_active IP Right Cessation
- 2007-06-06 WO PCT/EP2007/055608 patent/WO2007141309A2/en active Application Filing
- 2007-06-06 JO JO2007215A patent/JO2968B1/en active
- 2007-06-06 UA UAA200814196A patent/UA97953C2/uk unknown
- 2007-06-06 AU AU2007255419A patent/AU2007255419A1/en not_active Abandoned
- 2007-06-06 BR BRPI0712147-4A patent/BRPI0712147A2/pt not_active IP Right Cessation
- 2007-06-06 NZ NZ572548A patent/NZ572548A/en not_active IP Right Cessation
- 2007-06-06 CL CL200701614A patent/CL2007001614A1/es unknown
- 2007-06-06 DK DK07798148.8T patent/DK2032155T3/en active
- 2007-06-06 JP JP2009513697A patent/JP2009539805A/ja active Pending
- 2007-06-06 EP EP07798148.8A patent/EP2032155B1/en active Active
- 2007-06-06 BR BRPI0712052-4A patent/BRPI0712052A2/pt not_active Application Discontinuation
- 2007-06-06 AR ARP070102431A patent/AR061242A1/es unknown
- 2007-06-06 PE PE2007000699A patent/PE20080715A1/es not_active Application Discontinuation
- 2007-06-06 KR KR1020087029888A patent/KR101459789B1/ko active IP Right Grant
- 2007-06-06 NZ NZ572708A patent/NZ572708A/en not_active IP Right Cessation
- 2007-06-06 SI SI200731622T patent/SI2032155T1/sl unknown
- 2007-06-06 WO PCT/US2007/070468 patent/WO2007146689A2/en active Application Filing
- 2007-06-06 MX MX2008015657A patent/MX2008015657A/es not_active Application Discontinuation
- 2007-06-06 JP JP2009514507A patent/JP5290966B2/ja not_active Expired - Fee Related
- 2007-06-06 ES ES07798148.8T patent/ES2529261T3/es active Active
- 2007-06-06 MX MX2008015726A patent/MX2008015726A/es active IP Right Grant
- 2007-06-06 MY MYPI20084827A patent/MY147856A/en unknown
- 2007-06-06 PT PT77981488T patent/PT2032155E/pt unknown
- 2007-06-06 PL PL07798148T patent/PL2032155T3/pl unknown
- 2007-06-06 US US12/304,068 patent/US8343918B2/en not_active Expired - Fee Related
- 2007-06-06 AU AU2007257936A patent/AU2007257936B2/en not_active Ceased
- 2007-06-06 CA CA002653781A patent/CA2653781A1/en not_active Abandoned
- 2007-06-06 RU RU2008151511/10A patent/RU2477287C2/ru not_active IP Right Cessation
-
2008
- 2008-11-06 IL IL195156A patent/IL195156A/en not_active IP Right Cessation
- 2008-11-10 CR CR10432A patent/CR10432A/es unknown
- 2008-12-04 GT GT200800273A patent/GT200800273A/es unknown
- 2008-12-05 TN TNP2008000509A patent/TNSN08509A1/en unknown
- 2008-12-08 MA MA31459A patent/MA30503B1/fr unknown
- 2008-12-09 EC EC2008008949A patent/ECSP088949A/es unknown
- 2008-12-11 NO NO20085184A patent/NO20085184L/no not_active Application Discontinuation
- 2008-12-11 NO NO20085183A patent/NO20085183L/no not_active Application Discontinuation
-
2009
- 2009-01-06 DK DK200900016A patent/DK200900016A/da not_active Application Discontinuation
- 2009-06-17 HK HK09105411.1A patent/HK1126429A1/xx not_active IP Right Cessation
-
2012
- 2012-10-30 US US13/664,055 patent/US8722621B2/en not_active Expired - Fee Related
-
2014
- 2014-01-15 US US14/155,974 patent/US20170066808A9/en not_active Abandoned
-
2015
- 2015-03-13 CY CY20151100260T patent/CY1116117T1/el unknown
- 2015-03-23 HR HRP20150326TT patent/HRP20150326T1/hr unknown
-
2016
- 2016-03-07 CR CR20160115A patent/CR20160115A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20085184L (no) | Stabiliserte insulinlignende vekstfaktorpolypeptider | |
| MX2009010492A (es) | Elementos de vector de expresion recombinante (reves) para mejorar la expresion de proteinas recombinantes en celulas huesped. | |
| GEP20135967B (en) | Improved reconstituted surfactant composition containing surfactant protein b (sp-b), and surfactant protein c (sp-c) analogs | |
| UY31073A1 (es) | Inhibidores de la proteína activadora de la 5-lipoxigenasa (flap) | |
| IL190796A (en) | Composition containing nucleic acid encoded by anti-osteoclastogenic protein | |
| WO2008057162A3 (en) | Native (telopeptide) placental collagen compositions | |
| BRPI0519170A8 (pt) | formulações de hormônio de crescimento humano que compreendem um aminoácido não naturalmente codificado | |
| SG178797A1 (en) | Oligosaccharide chain added glp-1 peptide | |
| GEP20146056B (en) | Acylated glucagon analogues | |
| MY144470A (en) | Compounds, compositions and methods | |
| AR053259A1 (es) | Trigo con nuevo almidon y metodo para producirlo | |
| BRPI0512503A (pt) | composição que compreende ácido lático e lactoferrina | |
| MY160560A (en) | Compositions and methods for treatment of kidney disorders | |
| WO2008098169A3 (en) | Compositions and methods including expression and bioactivity of bovine follicle stimulating hormone | |
| WO2010142551A8 (en) | Amino acid sequences directed against receptors to cytokines belonging to the il-17 family | |
| MX2009003553A (es) | Uso de goma arabiga para mejorar el crecimiento y supervivencia de bifidobacteria. | |
| ATE472316T1 (de) | Haarbehandlungszusammensetzungen | |
| TW200628168A (en) | Use of organic compounds | |
| GB2530224A (en) | Enhancement of osteogenic potential of bone grafts | |
| MY180681A (en) | Compositions and methods for treatment of aortic fibrosis | |
| ATE526056T1 (de) | Igf-2 peptid zur verwendung in einer tolerogenen behandlung für typ i diabetes | |
| MX2009005550A (es) | Inhibidores de fosfatasa de proteina tirosina para la promocion de la hipertrofia cardiaca fisiologica. | |
| DK2118136T3 (da) | Konsensuspeptid | |
| GB0724626D0 (en) | Computer patch management | |
| ATE550351T1 (de) | Vegf-d-mutanten und ihre verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |